{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T20:48:11Z","timestamp":1768423691007,"version":"3.49.0"},"reference-count":55,"publisher":"IOP Publishing","issue":"4","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/iopscience.iop.org\/info\/page\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"crossref","award":["ALF-medel 20200123"],"award-info":[{"award-number":["ALF-medel 20200123"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["iopscience.iop.org"],"crossmark-restriction":false},"short-container-title":["J. Radiol. Prot."],"published-print":{"date-parts":[[2021,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The bronchial tolerance to high doses of radiation is not fully understood. However, in the event of a radiological accident with unintended exposure of the central airways to high doses of radiation it would be important to be able to anticipate the clinical consequences given the magnitude of the absorbed dose to different parts of the bronchial tree. Stereotactic body radiation therapy (SBRT) is a radiation treatment technique involving a few large fractions of photon external-beam radiation delivered to a well-defined target in the body. Despite generally favourable results, with high local tumour control and low-toxicity profile, its utility for tumours located close to central thoracic structures has been questioned, considering reports of severe toxic symptoms such as haemoptysis (bleedings from the airways), bronchial necrosis, bronchial stenosis, fistulas and pneumonitis. In conjunction with patient- and tumour-related risk factors, recent studies have analysed the absorbed radiation dose to different thoracic structures of normal tissue to better understand their tolerance to these high doses per fraction. Although the specific mechanisms behind the toxicity are still partly unknown, dose to the proximal bronchial tree has been shown to correlate with high-grade radiation side effects. Still, there is no clear consensus on the tolerance dose of the different bronchial structures. Recent data indicate that a too high dose to a main bronchus may result in more severe clinical side effects as compared to a smaller sized bronchus. This review analyses the current knowledge on the clinical consequences of bronchial exposure to high dose hypofractionated radiation delivered with the SBRT technique, and the tolerance doses of the bronchi. It presents the current literature regarding types of high-grade clinical side effects, data on dose response and comments on other risk factors for high-grade toxic effects.<\/jats:p>","DOI":"10.1088\/1361-6498\/ac28ef","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T22:28:09Z","timestamp":1632263289000},"page":"S355-S370","update-policy":"https:\/\/doi.org\/10.1088\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Medical consequences of radiation exposure of the bronchi\u2014what can we learn from high-dose precision radiation therapy?"],"prefix":"10.1088","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8996-2430","authenticated-orcid":false,"given":"Karin","family":"Lindberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9113-4044","authenticated-orcid":false,"given":"Eva","family":"Onjukka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"266","published-online":{"date-parts":[[2021,11,1]]},"reference":[{"key":"jrpac28efbib1","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.7326\/0003-4819-140-12-200406150-00015","article-title":"Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group","volume":"140","author":"Waselenko","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"jrpac28efbib2","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1200\/JCO.2008.21.5681","article-title":"Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy","volume":"27","author":"Baumann","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"jrpac28efbib3","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.3109\/0284186X.2015.1020966","article-title":"Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT\u2014the Nordic experience","volume":"54","author":"Lindberg","year":"2015","journal-title":"Acta Oncol."},{"key":"jrpac28efbib4","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman","year":"2010","journal-title":"JAMA"},{"key":"jrpac28efbib5","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.1200\/JCO.2006.07.5937","article-title":"Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer","volume":"24","author":"Timmerman","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"jrpac28efbib6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.lungcan.2008.12.016","article-title":"Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus","volume":"66","author":"Song","year":"2009","journal-title":"Lung Cancer"},{"key":"jrpac28efbib7","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.radonc.2013.01.004","article-title":"Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review","volume":"106","author":"Senthi","year":"2013","journal-title":"Radiother. Oncol."},{"key":"jrpac28efbib8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13014-018-1001-6","article-title":"Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?","volume":"13","author":"Murrell","year":"2018","journal-title":"Radiat. Oncol."},{"key":"jrpac28efbib9","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.jtho.2016.03.008","article-title":"Outcomes of hypofractionated high-dose radiotherapy in poor-risk patients with \u2018ultracentral\u2019 non-small cell lung cancer","volume":"11","author":"Tekatli","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"jrpac28efbib10","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.ijrobp.2017.11.022","article-title":"Normal tissue complication probability modeling of pulmonary toxicity after stereotactic and hypofractionated radiation therapy for central lung tumors","volume":"100","author":"Tekatli","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"jrpac28efbib11","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1016\/j.prro.2015.09.012","article-title":"Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree","volume":"6","author":"Haseltine","year":"2016","journal-title":"Pract. Radiat. Oncol."},{"key":"jrpac28efbib12","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.jtho.2021.03.019","article-title":"The HILUS-trial\u2014a prospective Nordic multicenter phase 2 study of ultracentral lung tumors treated with stereotactic body radiotherapy","volume":"16","author":"Lindberg","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"jrpac28efbib13","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1200\/JCO.2008.19.6329","article-title":"Multi-institutional phase I\/II trial of stereotactic body radiation therapy for liver metastases","volume":"27","author":"Rusthoven","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"jrpac28efbib14","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.ijrobp.2018.11.051","article-title":"Long-term follow-up on NRG oncology RTOG 0915 (NCCTG N0927): a randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer","volume":"103","author":"Videtic","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"jrpac28efbib15","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1200\/JCO.18.00622","article-title":"Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non-small-cell lung cancer: NRG oncology\/RTOG 0813 trial","volume":"37","author":"Bezjak","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"jrpac28efbib16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.lungcan.2015.04.014","article-title":"Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors","volume":"89","author":"Chaudhuri","year":"2015","journal-title":"Lung Cancer"},{"key":"jrpac28efbib17","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.radonc.2021.03.001","article-title":"Ablative radiotherapy for ultracentral lung cancers: dosimetric, geometric, and volumetric predictors of outcomes and toxicity","volume":"158","author":"Breen","year":"2021","journal-title":"Radiother. Oncol."},{"key":"jrpac28efbib18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.lungcan.2020.07.009","article-title":"Analysis of pneumonitis and esophageal injury after stereotactic body radiation therapy for ultra-central lung tumors","volume":"147","author":"Wang","year":"2020","journal-title":"Lung Cancer"},{"key":"jrpac28efbib19","article-title":"Common criteria for clinical adverse events","author":""},{"key":"jrpac28efbib20","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.ijrobp.2010.04.056","article-title":"Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a phase II trial","volume":"80","author":"Bral","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"jrpac28efbib21","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.radonc.2015.09.028","article-title":"Stereotactic ablative radiotherapy (SABR) for central lung tumors: plan quality and long-term clinical outcomes","volume":"117","author":"Tekatli","year":"2015","journal-title":"Radiother. Oncol."},{"key":"jrpac28efbib22","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1097\/JTO.0b013e3182614bf3","article-title":"Stereotactic body radiotherapy for central lung tumors","volume":"7","author":"Rowe","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"jrpac28efbib23","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s00066-010-2072-y","article-title":"Stereotactic body radiotherapy for lung tumors at the pulmonary hilum","volume":"186","author":"Oshiro","year":"2010","journal-title":"Strahlenther. Onkol."},{"key":"jrpac28efbib24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.semradonc.2015.11.002","article-title":"Dose and volume of the irradiated main bronchi and related side effects in the treatment of central lung tumors with stereotactic radiotherapy","volume":"26","author":"Duijm","year":"2016","journal-title":"Semin. Radiat. Oncol."},{"key":"jrpac28efbib25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1080\/09553002.2019.1552375","article-title":"Is stereotactic body radiotherapy for ultra-central lung tumor a feasible option? A systemic review and meta-analysis","volume":"95","author":"Rim","year":"2019","journal-title":"Int. J. Radiat. Biol."},{"key":"jrpac28efbib26","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.jtho.2019.04.018","article-title":"Safety and effectiveness of stereotactic ablative radiotherapy for ultra-central lung lesions: a systematic review","volume":"14","author":"Chen","year":"2019","journal-title":"J. Thorac. Oncol."},{"key":"jrpac28efbib27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.radonc.2018.07.001","article-title":"The safety and effectiveness of stereotactic body radiotherapy for central versus ultracentral lung tumors","volume":"129","author":"Chang","year":"2018","journal-title":"Radiother. Oncol."},{"key":"jrpac28efbib28","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1097\/JTO.0000000000000260","article-title":"Toxicities of organs at risk in the mediastinal and hilar regions following stereotactic body radiotherapy for centrally located lung tumors","volume":"9","author":"Nishimura","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"jrpac28efbib29","doi-asserted-by":"publisher","first-page":"e196","DOI":"10.1016\/j.prro.2018.11.005","article-title":"Tumor control and toxicity after SBRT for ultracentral, central, and paramediastinal lung tumors","volume":"9","author":"Nguyen","year":"2019","journal-title":"Pract. Radiat. Oncol."},{"key":"jrpac28efbib30","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.adro.2019.01.002","article-title":"Long-term clinical outcomes and safety profile of SBRT for centrally located NSCLC","volume":"4","author":"Arnett","year":"2019","journal-title":"Adv. Radiat. Oncol."},{"key":"jrpac28efbib31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1756-8722-3-39","article-title":"CyberKnife for hilar lung tumors: report of clinical response and toxicity","volume":"3","author":"Unger","year":"2010","journal-title":"J. Hematol. Oncol."},{"key":"jrpac28efbib32","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.ijrobp.2013.06.2055","article-title":"Retrospective cohort study of bronchial doses and radiation-induced atelectasis after stereotactic body radiation therapy of lung tumors located close to the bronchial tree","volume":"87","author":"Karlsson","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"jrpac28efbib33","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ijrobp.2020.01.009","article-title":"Validation of RTOG 0813 proximal bronchial tree constraints for pulmonary toxicity with stereotactic body radiation therapy for central non-small cell lung cancer","volume":"107","author":"Manyam","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"jrpac28efbib34","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1056\/NEJMc1203770","article-title":"Central-airway necrosis after stereotactic body-radiation therapy","volume":"366","author":"Corradetti","year":"2012","journal-title":"New Engl. J. Med."},{"key":"jrpac28efbib35","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1001\/jamaoncol.2019.0205","article-title":"Analysis of toxic effects with antiangiogenic agents plus stereotactic body radiation in ultracentral lung tumors","volume":"5","author":"Wang","year":"2019","journal-title":"JAMA Oncol."},{"key":"jrpac28efbib36","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13014-016-0608-8","article-title":"Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases","volume":"11","author":"Lischalk","year":"2016","journal-title":"Radiat. Oncol."},{"key":"jrpac28efbib37","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1111\/cas.14185","article-title":"Risk-adapted stereotactic body radiation therapy for central and ultra-central early-stage inoperable non-small cell lung cancer","volume":"110","author":"Meng","year":"2019","journal-title":"Cancer Sci."},{"key":"jrpac28efbib38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.tipsro.2020.01.002","article-title":"Stereotactic body radiotherapy for moderately central and ultra-central oligometastatic disease: initial outcomes","volume":"13","author":"Cooke","year":"2020","journal-title":"Tech. Innov. Patient Support Radiat. Oncol."},{"key":"jrpac28efbib39","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.radonc.2009.10.017","article-title":"Low rate of thoracic toxicity in palliative paraspinal single-fraction stereotactic body radiation therapy","volume":"93","author":"Gomez","year":"2009","journal-title":"Radiother. Oncol."},{"key":"jrpac28efbib40","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.radonc.2011.12.023","article-title":"Outcome of four-dimensional stereotactic radiotherapy for centrally located lung tumors","volume":"102","author":"Nuyttens","year":"2012","journal-title":"Radiother. Oncol."},{"key":"jrpac28efbib41","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.cllc.2020.11.003","article-title":"Safety and efficacy of stereotactic body radiotherapy in ultracentral lung tumors using a risk-optimized fractionation scheme","volume":"22","author":"Regnery","year":"2021","journal-title":"Clin. Lung Cancer"},{"key":"jrpac28efbib42","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.clon.2019.09.055","article-title":"Toxicity and efficacy of stereotactic ablative body radiotherapy for moderately central non-small cell lung cancers using 50 Gy in five fractions","volume":"32","author":"Rulach","year":"2020","journal-title":"Clin. Oncol."},{"key":"jrpac28efbib43","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/1759-7714.13335","article-title":"Stereotactic ablative radiotherapy of 60 Gy in eight fractions is safe for ultracentral non-small cell lung cancer","volume":"11","author":"Yang","year":"2020","journal-title":"Thorac. Cancer"},{"key":"jrpac28efbib44","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.ijrobp.2014.08.008","article-title":"Local control and toxicity in a large cohort of central lung tumors treated with stereotactic body radiation therapy","volume":"90","author":"Modh","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"jrpac28efbib45","first-page":"4498","article-title":"Stereotactic body radiotherapy for centrally-located lung tumors with 56 Gy in seven fractions: a retrospective study","volume":"16","author":"Aoki","year":"2018","journal-title":"Oncol. Lett."},{"key":"jrpac28efbib46","article-title":"Prescribing, recording and reporting photon-beam intensity modulated radiation therapy (IMRT)","volume":"10","author":"","year":"2010","journal-title":"J. ICRU Oxford Univ. Press"},{"key":"jrpac28efbib47","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.5858\/arpa.2011-0521-OA","article-title":"Causes of death of patients with lung cancer","volume":"136","author":"Nichols","year":"2012","journal-title":"Arch. Pathol. Lab. Med."},{"key":"jrpac28efbib48","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/JTO.0b013e3181915028","article-title":"Late complications of high-dose (>\/ = 66 Gy) thoracic conformal radiation therapy in combined modality trials in unresectable stage III non-small cell lung cancer","volume":"4","author":"Lee","year":"2009","journal-title":"J. Thorac. Oncol."},{"key":"jrpac28efbib49","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.1200\/JCO.2004.03.022","article-title":"Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: a dose-escalation phase I trial","volume":"22","author":"Socinski","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"jrpac28efbib50","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.ijrobp.2020.05.026","article-title":"Central airway toxicity after high dose radiation: a combined analysis of prospective clinical trials for non-small cell lung cancer","volume":"108","author":"Wang","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"jrpac28efbib51","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0360-3016(97)00008-4","article-title":"Does additional brachytherapy improve the effect of external irradiation? A prospective, randomized study in central lung tumors","volume":"38","author":"Huber","year":"1997","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"jrpac28efbib52","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.radonc.2020.04.033","article-title":"Accelerated hypofractionated radiotherapy with concurrent full dose chemotherapy for locally advanced non-small cell lung cancer: a phase I\/II study","volume":"148","author":"Glinski","year":"2020","journal-title":"Radiother. Oncol."},{"key":"jrpac28efbib53","doi-asserted-by":"publisher","DOI":"10.1088\/1742-6596\/489\/1\/012093","article-title":"An investigation of the impact of variations of DVH calculation algorithms on DVH dependant radiation therapy plan evaluation metrics","volume":"489","author":"Kennedy","year":"2014","journal-title":"J. Phys.: Conf. Ser."},{"key":"jrpac28efbib54","doi-asserted-by":"publisher","first-page":"e529","DOI":"10.1016\/j.cllc.2018.04.001","article-title":"SUNSET: stereotactic radiation for ultracentral non-small-cell lung cancer-a safety and efficacy trial","volume":"19","author":"Giuliani","year":"2018","journal-title":"Clin. Lung Cancer"},{"key":"jrpac28efbib55","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ijrobp.2018.11.028","article-title":"Organs at risk considerations for thoracic stereotactic body radiation therapy: what is safe for lung parenchyma?","volume":"110","author":"Kong","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."}],"container-title":["Journal of Radiological Protection"],"original-title":[],"link":[{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6498\/ac28ef","content-type":"text\/html","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6498\/ac28ef\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6498\/ac28ef","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6498\/ac28ef\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6498\/ac28ef\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6498\/ac28ef\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6498\/ac28ef\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"similarity-checking"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6498\/ac28ef\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T17:46:49Z","timestamp":1637689609000},"score":1,"resource":{"primary":{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1361-6498\/ac28ef"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":55,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,11,1]]},"published-print":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1088\/1361-6498\/ac28ef","relation":{},"ISSN":["0952-4746","1361-6498"],"issn-type":[{"value":"0952-4746","type":"print"},{"value":"1361-6498","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,1]]},"assertion":[{"value":"Medical consequences of radiation exposure of the bronchi\u2014what can we learn from high-dose precision radiation therapy?","name":"article_title","label":"Article Title"},{"value":"Journal of Radiological Protection","name":"journal_title","label":"Journal Title"},{"value":"paper","name":"article_type","label":"Article Type"},{"value":"\u00a9 2021 The Author(s). Published on behalf of the Society for Radiological Protection by IOP Publishing Ltd","name":"copyright_information","label":"Copyright Information"},{"value":"2021-06-22","name":"date_received","label":"Date Received","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2021-09-21","name":"date_accepted","label":"Date Accepted","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2021-11-01","name":"date_epub","label":"Online publication date","group":{"name":"publication_dates","label":"Publication dates"}}]}}